Legal Representation
Attorney
Aaron D. Hendelman
USPTO Deadlines
Next Deadline
1738 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-08-13)
Due Date
August 13, 2030
Grace Period Ends
February 13, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
33 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 3, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Apr 3, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 3, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Apr 3, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Apr 3, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 13, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 13, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 10, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jul 10, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 30, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Apr 29, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 8, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Apr 8, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Apr 4, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 4, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 4, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 4, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 2, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 2, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 2, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 18, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 21, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 21, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 1, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 17, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 17, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 17, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 17, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 17, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 9, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 29, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 28, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of neuromuscular and cardiac disorders and diseases
First Use Anywhere:
Jan 3, 2024
First Use in Commerce:
Jan 3, 2024
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"